Prevalence of Shared Decision-making in Prostate Cancer Screening in New York State

J Immigr Minor Health. 2023 Oct;25(5):1207-1210. doi: 10.1007/s10903-023-01482-5. Epub 2023 Apr 21.

Abstract

Current guidelines recommend that physicians use a shared decision-making (SDM) approach to engage with patients on the potential benefits and harms of prostate cancer screening based on their individual risk. In a sample of 4,118 men aged 55-69 from the 2018 New York State Behavioral Risk Factor Surveillance Survey (BRFSS), we compared the frequency of screening recommendations and SDM conversations according to four race/ethnic groups. In logistic regression, we evaluated the likelihood of SDM conversations between race/ethnic groups. Our findings suggest that the odds of never having a SDM conversation with their healthcare provider were significantly higher among Hispanic men (OR 95% CI: 2.10, 1.11-3.99) and other/multiracial men (OR, 95% CI: 3.08, 1.46-6.52) compared to white men, while black men had comparable odds (1.52, 0.98-2.34). The lower frequency of SDM conversation among Hispanic and other/multiracial men suggest a missed opportunity for healthcare providers to guide informed screening decisions.

Keywords: Cancer prevention; Health disparity; PSA test; Prostate cancer screening; Racial disparity.

MeSH terms

  • Decision Making
  • Early Detection of Cancer
  • Humans
  • Male
  • Mass Screening
  • New York
  • Prevalence
  • Prostate-Specific Antigen
  • Prostatic Neoplasms* / diagnosis

Substances

  • Prostate-Specific Antigen